Jason Robins
Equibles does not estimate personal net worth.
About Jason Robins
Jason Robins is recorded as CFO at Ocular Therapeutix, Inc (OCUL). The newest filing on record that lists Jason Robins as CFO at Ocular Therapeutix, Inc (OCUL) is dated April 30, 2026. Ocular Therapeutix, Inc reported in an 8-K filed June 12, 2026 that Jason Robins was appointed Chief Financial Officer, effective June 10, 2026. Ocular Therapeutix, Inc reported in an 8-K filed January 23, 2026 that Jason Robins was appointed interim Chief Financial Officer, effective January 20, 2026. Ocular Therapeutix, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ocular Therapeutix, Inc includes Pravin Dugel (CEO), Pravin U. Dugel (CEO, Chairman and Board Member), Pravin U. Dugel, M.D. (CEO and Chairman) and 7 others.
“On June 10, 2026, the Board appointed Jason Robins, the Company's interim Chief Financial Officer, to serve as the Chief Financial Officer.”
“the Company's Board of Directors appointed Jason Robins, the Company's Senior Vice President, Finance, to serve as the Company's interim Chief Financial Officer until Mr. Notman's anticipated return.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2026
Company network
Leadership on record at Ocular Therapeutix, Inc
- Pravin Dugel CEO
- Pravin U. Dugel CEO, Chairman, Board Member
- Pravin U. Dugel, M.D. CEO, Chairman
- Charles Warden Chairman, Board Member
- Donald Notman COO
- Philip C. Strassburger General Counsel
- Adrienne L. Graves Board Member
- Adrienne L. Graves, Ph.D. Board Member
- Jeffrey Heier Board Member
- Jeffrey S. Heier, M.D. Board Member